| Spirig HealthCare AG - Ruxolitinib Spirig HC 20 mg, Tabletten |
| 70513 | | 04 | | Ruxolitinib Spirig HC 20 mg | | Tabletten | | L01EJ01 | | Ruxolitinib | | 15.10.2026 | | |
|
| Composition |
| ruxolitinibum 20 mg ut ruxolitinibum dihydricum, cellulosum microcristallinum, lactosum monohydricum 300.8 mg, hydroxypropylcellulosum, carboxymethylamylum natricum A corresp. natrium max. 0.84 mg, silica colloidalis anhydrica, magnesii stearas, pro compresso. |
| Packungsbestandteile |
| Tablets | | | | Active Agent | Dose |
|---|
| Ruxolitinibum | 20 mg |
| | | | Inactive agents | Dose |
|---|
| Carboxymethylamylum Natricum A | | | Cellulosum Microcristallinum | | | Hydroxypropylcellulosum | | | Lactose Monohydrate | 300.8 mg | | Magnesii Stearas | | | Pro Compresso | | | Silica Colloidalis Anhydrica | |
|
|
| Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 004 | 56 | | | A | | Yes |
|
